Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors

resourcesSIRION Biotech GmbH
October 27th 2022

SIRION provides a 360° solution from early R&D up to the late preclinical AAV vector space to develop safe and efficacious AAV-based drug products. Please click on the brochure below to learn more:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications

FREE DOWNLOAD

SIRION Biotech GmbH

Contact Information
Address: Am Haag 6, 82166 Graefelfing, Germany
Telephone No: +49 89 700 961 99 0
Email Address: [email protected]